Demo Data from VLDB 2026 / reviewers in the wild / expert
Ki-Hwa Kim
dblp:430/3686
· DBLP profile ↗
1ranked-venue papers
1as first author
1since 2021 · last 2026
—ORCID · none
Domains — the database's venue-derived domains; a paper can count in several
Applied, interdisciplinary, general and emerging computing · 1 · 1 first-author · 1 since 2021
Expertise — from the expertise taxonomy: the topics of the expert's papers under the CCF categories. A weight counts papers with recency: 1 for a paper about the topic, 0.3 when the topic is its context, halved every five years.
| Interdisciplinary, comprehensive, and emerging computing
1 paper |
Bioinformatics and computational biology · 67% Computational science and engineering · 33% |
Topics — the 3 heaviest of 3, each with the papers that count most for it
| Topic | Weight | Papers | Last | Evidence papers |
|---|---|---|---|---|
Bioinformatics and computational biology › drug discovery
drug-target interaction prediction |
1.0 | 1 | 2026 | Prediction of bacterial protein-compound interactions with only positive samples · Bioinform. 2026 |
Bioinformatics and computational biology › drug discovery › computational drug discovery
machine learning for drug discovery |
1.0 | 1 | 2026 | Prediction of bacterial protein-compound interactions with only positive samples · Bioinform. 2026 |
Computational science and engineering
positive-unlabeled learning |
1.0 | 1 | 2026 | Prediction of bacterial protein-compound interactions with only positive samples · Bioinform. 2026 |
Methods — techniques the papers use, named apart from their topics
weighted positive loss · 1.0positive-unlabeled learning · 1.0deep learning · 1.0
| Year | Publication | Venue | Position |
|---|---|---|---|
| 2026 | Prediction of bacterial protein-compound interactions with only positive samplesabstractMOTIVATION: Prediction of Compound-Protein Interactions (CPI) in bacteria is crucial to advance various pharmaceutical and chemical engineering fields, including biocatalysis, drug discovery, and industrial processing. However, current CPI models cannot be applied for bacterial CPI prediction due to the lack of curated negative interaction samples. RESULTS: We propose a novel Positive-Unlabeled (PU) learning framework, named BIN-PU, to address this limitation. BIN-PU generates pseudo positive and negative labels from known positive interaction data, enabling effective training of deep learning models for CPI prediction. We also propose a weighted positive loss function that weights to truly positive samples. We have validated BIN-PU coupled with multiple CPI backbone models, comparing the performance with the existing PU models using bacterial cytochrome P450 (CYP) data. Extensive experiments demonstrate the superiority of BIN-PU over the benchmark models in predicting CPIs with only truly positive samples. Furthermore, we have validated BIN-PU on additional bacterial proteins obtained from literature review, human CYP datasets, and uncurated data for its reproducibility. We have also validated the CPI prediction for the uncurated CYP data with biological and biophysical experiments. BIN-PU represents a significant advancement in CPI prediction for bacterial proteins, opening new possibilities for improving predictive models in related biological interaction tasks. AVAILABILITY AND IMPLEMENTATION: The source code and data are available at https://github.com/datax-lab/CYP. Ki-Hwa Kim, Avinash Yaganapu, Sai Kosaraju, Aashish Bhatt, Yun Lyna Luo, Sai Phani Krishna Parsa, Hyun Lee 0004, Jun Hyuck Lee, Tae-Jin Oh, Mingon Kang |
Bioinform. | 1 |